Time to Undetectable Viral Load after Highly Active Antiretroviral Therapy Initiation among HIV-Infected Pregnant Women
Open Access
- 15 June 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 44 (12) , 1647-1656
- https://doi.org/10.1086/518284
Abstract
Background. There have been no clinical trials in resource-rich regions that have addressed the question of which highly active antiretroviral therapKeywords
This publication has 28 references indexed in Scilit:
- An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adultsAIDS, 2006
- Reduced lopinavir exposure during pregnancyAIDS, 2006
- The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the WestAIDS, 2006
- Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremiaAIDS, 2006
- Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant womenBritish Journal of Clinical Pharmacology, 2006
- Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2005
- Nelfinavir Plasma Concentrations Are Low during PregnancyClinical Infectious Diseases, 2004
- Pharmacokinetics of Antiretrovirals in Pregnant WomenClinical Pharmacokinetics, 2004
- Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trialsAIDS, 1999
- Effect of Pregnancy and Zidovudine Therapy on Viral Load in HIV-1-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997